Cannabinoids

“”‘ + ‘ width=0 height=0 border=0 frameborder=0 style=”position: absolute; top: -9999em; width: 10px; height: 10px;”‘ + ” + ” + ” + ”; container.parentNode.insertBefore(div.firstChild, container); } else { googletag.cmd.push(function() { var path = ‘/this-cannabinoid-infused-chocolate-could-be-the-next-trend-in-treating-anxiety/’; googletag.pubads().addEventListener( …read more at https://www.brit.co/this-cannabinoid-infused-chocolate-could-be-the-next-trend-in-treating-anxiety/

by

“”‘ + ‘ width=0 height=0 border=0 frameborder=0 style=”position: absolute; top: -9999em; width: 10px; height: 10px;”‘ + ” + ” + ” + ”; container.parentNode.insertBefore(div.firstChild, container); } else { googletag.cmd.push(function() { var path = ‘/this-cannabinoid-infused-chocolate-could-be-the-next-trend-in-treating-anxiety/’; googletag.pubads().addEventListener( …read more at https://www.brit.co/this-cannabinoid-infused-chocolate-could-be-the-next-trend-in-treating-anxiety/

by

TORONTO, ONTARIO–(Marketwired – Oct. 19, 2017) – Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel treatments for serious and unmet medical needs in the medical cannabis and cannabinoid pharmaceuticals sectors, today announced its results for the fiscal year ended June 30, 2017. […]

by

If you a) struggle with anxiety, and b) love chocolate, I have some excellent news for you: “Not Pot” chocolate is infused with cannabinoids, and it’s meant to help you manage your anxiety. Although cannabinoids aren’t necessarily be gearing up to replace other anti-anxiety medications (or at least, not yet), research has shown that marijuana […]

by

LAS VEGAS, Oct. 17, 2017 /PRNewswire/ – GB Sciences, Inc. (OTCQB: GBLX) has obtained the exclusive worldwide license to intellectual property covering a time-released cannabinoid formulation from the Universidad de Seville (“USE”), the Universidad de Cadiz (“UCA”), and the Centro de Investigación Biomédica en Red de Salud Mental (“CIBERSAM”). “GB Sciences recognizes the ineffectiveness of current […]

by

LOS ANGELES, CA–(Marketwired – Oct 19, 2017) – Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced additional positive preclinical efficacy results for the treatment of colitis. […]

by

LOS ANGELES, CA–(Marketwired – Oct 16, 2017) – Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the publication of an international PCT patent application that covers […]

by

“GB Sciences recognizes the ineffectiveness of current delivery methods for cannabis-based medicines (i.e., smoking, vaping, sublingual, and ingestion), and therefore licensed this innovative new cannabinoid nanotechnology from the University of Seville,” explained Dr. Andrea Small-Howard, Chief Science Officer. “Dr. Mercedes Fernández Arévalo and Dr. Lucía Martín Banderas are leading the industry in the development of […]

by

Renal cell carcinoma (RCC) is the most common malignancy of urogenital system, and patients with RCC may face a poor prognosis. However, limited curable therapeutic options are currently available. The aim of this study is to investigate the role of Cannabinoid receptor 2 (CB2) in RCC progression. Immunohistochemistry was to investigate the expression pattern of […]

by

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that its research partner, the University of Northern Colorado (UNC), has identified an organism whose genome contains the genetic code for production of […]

by

SARASOTA, Fla., Oct. 17, 2017 (GLOBE NEWSWIRE) — BluDog Products LLC, a subsidiary of International Consolidated Companies, Inc. (OTC:INCC), has executed a license agreement with Raderman Holdings LLC, based in Boulder, CO, for a Carbon 60 Molecule (“C60”) Cannabinoid Anti-Aging Formulation Patent Application. “C60 is a soccer ball shaped carbon molecule that has the incredible […]

by

CSE: INOTCQB: IMLFF VANCOUVER, Oct. 17, 2017 /CNW/ – InMed Pharmaceuticals, Inc. (“InMed” or the “Company”) (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today additional pre-clinical results in the development of INM-405 for the treatment of pain. In recent pre-clinical testing, InMed employed several […]

by

SARASOTA, Fla., Oct. 17, 2017 (GLOBE NEWSWIRE) — BluDog Products LLC, a subsidiary of International Consolidated Companies, Inc. (OTC:INCC), has executed a license agreement with Raderman Holdings LLC, based in Boulder, CO, for a Carbon 60 Molecule (“C60”) Cannabinoid Anti-Aging Formulation Patent Application. “C60 is a soccer ball shaped carbon molecule that has the incredible […]

by

LAS VEGAS, Oct. 17, 2017 /PRNewswire/ – GB Sciences, Inc. (OTCQB: GBLX) has obtained the exclusive worldwide license to intellectual property covering a time-released cannabinoid formulation from the Universidad de Seville (“USE”), the Universidad de Cadiz (“UCA”), and the Centro de Investigación Biomédica en Red de Salud Mental (“CIBERSAM”). “GB Sciences recognizes the ineffectiveness of current […]

by

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that its research partner, the University of Northern Colorado (UNC), has identified an organism whose genome contains the genetic code for production of […]

by